Pharmacokinetics and safety assessment of tosufloxacin tosilate.
Niki
Yoshihito
Y
Division of Respiratory Diseases, Department of Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama 701-0192, Japan. niki@med.kawasaki-m.ac.jp
D000328:Adult; D000367:Age Factors; D000368:Aged; D000818:Animals; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000493:pharmacokinetics*; D002648:Child; D004347:Drug Interactions; D024841:Fluoroquinolones; D006801:Humans; D009287:Naphthyridines / Q000009:adverse effects / Q000493:pharmacokinetics*; D006435:Renal Dialysis; D051437:Renal Insufficiency / Q000378:metabolism; D014018:Tissue Distribution
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D009287:Naphthyridines; C055185:tosufloxacin